Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
Clinical trial NCT05067348 · RECRUITING
Trial details
- NCT number
- NCT05067348
- Sponsor
- Tang-Du Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2025-12-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.